Cargando…
Identification of barriers to insulin therapy and approaches to overcoming them
Poor glycaemic control in type 2 diabetes (T2D) is a global problem despite the availability of numerous glucose‐lowering therapies and clear guidelines for T2D management. Tackling clinical or therapeutic inertia, where the person with diabetes and/or their healthcare providers do not intensify tre...
Autores principales: | Russell‐Jones, David, Pouwer, Frans, Khunti, Kamlesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836933/ https://www.ncbi.nlm.nih.gov/pubmed/29053215 http://dx.doi.org/10.1111/dom.13132 |
Ejemplares similares
-
CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them
por: Vanhooren, Jolien, et al.
Publicado: (2023) -
Starting insulin in type 2 diabetes: Overcoming barriers to insulin therapy
por: Kabadi, Udaya M.
Publicado: (2008) -
Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and
methods to overcome inertia
por: Khunti, Sachin, et al.
Publicado: (2019) -
Therapeutic antibodies – natural and pathological barriers and strategies to overcome them
por: Al Ojaimi, Yara, et al.
Publicado: (2022) -
Barriers to Sustained Implementation of STAR-VA and Strategies to Overcome Them
por: Sullivan, Jennifer, et al.
Publicado: (2021)